Clinical TrialID 7214
The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health
NCT05258513
Sexual Health|Libido
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7214
- Evidence Id
- 7214
- Core Evidence Id
- 7214
- Source Clinical Trial Id
- 7204
- Herb2 Clinical Trial Id
- HBCT007204
- Nct Id
- NCT05258513
- Title
- The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health
- Status
- Completed
- Phase
- Study Result
- No
- Study Condition
- Sexual Health|Libido
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DIETARY_SUPPLEMENT: Placebo Supplementation|DIETARY_SUPPLEMENT: GG sourced from Annatto
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Triple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult
- Enrollment
- 83
- Outcome Measure
- Changes in Overall Sexual Function, Assessed by administering the Derogatis Interview for Sexual Functioning (DISF-SR) for subjective measurement. Values range from 0 to 8 with higher scores demonstrating a better outcome., Week 0, 4 and 8|Changes in Aging Male Symptoms, Assessed by administering the Aging Male Symptoms scale to males for subjective measurement. Values range from 1 to 5 with lower scores demonstrating a better outcome., Week 0, 4, and 8|Changes in Androgen Deficiency in Aging Males Scale, Assessed by administering the Androgen Deficiency in Aging Males scale to males for subjective measurement. Values range from 1 to 5 with higher scores demonstrating a better outcome., Week 0, 4, and 8|Changes in Satisfaction to Treatment, Assessed by administering the Erectile Dysfunction Interview for Treatment Satisfaction (EDITS) to males for subjective measurement. Values range from 0 to 4 with lower scores demonstrating a better outcome., Week 4 and 8|Changes in Erection Hardness, Assessed by administering the Erection Hardness Score (EHS) to males for subjective measurement. Values range from 0 to 4 with higher scores demonstrating a better outcome., Week 0, 4 and 8|Changes in Erectile Function, Assessed by administering the International Index of Erectile Function (IIEF) to males for subjective measurement. Values range from 0 to 5 with higher scores demonstrating a better outcome., Week 0, 4 and 8|Changes in Female Sexual Function, Assessed by administering the Female Sexual Function Index to females for subjective measurement. Values range from 0 to 5 with higher scores demonstrating a better outcome., Week 0, 4 and 8|Changes in Hot Flashes, Assessed by administering the Hot Flashes and Night Sweats questionnaire to females for subjective measurement. Values range from 0 to 10 with lower scores demonstrating a better outcome., Week 0, 4 and 8|Changes in Night Sweats, Assessed by administering the Hot Flashes and Night Sweats questionnaire to females for subjective measurement. Values range from 0 to 10 with lower scores demonstrating a better outcome., Week 0, 4 and 8
- Sponsor Collaborator
- Applied Science & Performance Institute
- Funded By
- INDUSTRY
- Location
- Applied Science and Performance Institute, Tampa, Florida, 33607, United States
- Other Id
- 122102
- Start Date
- 2022-02-06
- Primary Completion Date
- 2022-12-09
- Completion Date
- 2022-12-09
- First Posted
- 2022-02-28
- Results First Posted
- Last Update Posted
- 2022-12-29
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05258513
- Title Cn
- Title En
- The Effects of Geranylgeraniol (GG) Sourced From Annatto on Sexual Health
- Bilingual Status
- semi_complete